Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: iRadimed Corporation, 3 years.
iRadimed Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
iRadimed Corporation June 24, 202687.3%
-
iRadimed Corporation June 23, 202586.1%
-
iRadimed Corporation June 20, 202489.0%
-
iRadimed Corporation June 15, 202386.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 3, 2026 | iRadimed Corporation | Open-market sale | −1,014 | $86.44 | $87,650 |
| Sep 3, 2026 | iRadimed Corporation | Open-market sale | −405 | $86.35 | $34,972 |
| Feb 13, 2026 | iRadimed Corporation | Open-market sale | −1,000 | $100.26 | $100,260 |
| Dec 11, 2025 | iRadimed Corporation | Option exercise | +905 | — | — |
| Dec 7, 2025 | iRadimed Corporation | Option exercise | +1,197 | — | — |
| Aug 6, 2025 | iRadimed Corporation | Open-market sale | −1,102 | $69.10 | $76,148 |
| Dec 7, 2024 | iRadimed Corporation | Option exercise | +1,751 | — | — |
| Dec 7, 2024 | iRadimed Corporation | Option exercise | +1,196 | — | — |
| Jun 3, 2024 | iRadimed Corporation | Open-market sale | −1,947 | $43.37 | $84,441 |
| Dec 7, 2023 | iRadimed Corporation | Option exercise | +1,036 | — | — |
| Dec 7, 2023 | iRadimed Corporation | Option exercise | +1,750 | — | — |
| May 10, 2023 | iRadimed Corporation | Open-market sale | −2,786 | $46.03 | $128,240 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.